5-FU |
5-fluorouracil |
ALCL |
anaplastic large cell lymphoma |
Apt |
aptamer |
ATP |
adenosine triphosphate |
AuNPs |
gold nanoparticles |
CD133 |
differentiation antigen 133 |
CLPs |
cationic liposomes |
CRC |
colorectal cancer |
CSCs |
cancer stem cells |
CTCs |
circulating tumor cells |
DOX |
doxorubicin |
DTNs |
DNA tetrahedron nanostructures |
DTX |
docetaxel |
EGFR |
epidermal growth factor receptor |
EpCAM |
epithelial cell adhesion molecule |
EPI |
epirubicin |
FITC |
fluorescein isothiocyanate |
G4 |
G-tetramer |
GSH |
glutathione |
HCC |
hepatocellular carcinoma |
HPMA |
N-(2-hydroxypropyl) methylacrylamide |
JNPs |
janus nanoparticles |
MNPs |
magnetic nanoparticles |
MREs |
molecular recognition elements |
MSNs |
mesoporous silica nanoparticles |
MUC1 |
mucin 1 |
MUC16 |
mucin16 |
NPs |
nanoparticles |
OXA |
oxaliplatin |
PA |
pyrochlorophyll A |
PAM |
polyacrylamide |
PCR |
polymerase chain reaction |
PEG |
polyethylene glycolpegylated |
PEI |
polyetherimide |
PLGA |
poly(lactic-co-glycolic acid) |
PMA |
phorbol-12-myristate-13-acetate |
PTX |
paclitaxel |
QDs |
quantum dots |
ROS |
reactive oxygen species |
SELEX |
exponential enrichment |
siBraf |
anti-BRAF siRNA |
SLNs |
solid lipid nanoparticles |
ssRNA |
partial complementary paired RNA |
TFO |
triplex forming oligonucleotides |
TME |
tumor microenvironment |
TNBC |
triple-negative breast cancer |
TSIIA |
tanshinone II-A |
VEGF |
vascular endothelial growth factor |